SECURITIES AND EXCHANGE COMMISSION
Washington, D. C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): November 18, 2004
INYX, INC.
(Exact name of registrant as specified in its charter)
Nevada 333-83152 75-2870720
- ------ --------- ----------
(State or other jurisdiction (Commission (I.R.S. Employer
of incorporation) File Number) Identification No.)
825 Third Avenue, 40th Floor, New York, NY 10022
------------------------------------------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (212) 838-1111
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):
[_] Written communications pursuant to Rule 425 under the Securities Act
(17 CFR 230.425)
[_] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17
CFR 240.14a-12)
[_] Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
[_] Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
Item 1.01. Entry into a Material Definitive Agreement
On November 18, 2004, a subsidiary of Registrant signed a Manufacturing
and Supply Agreement with NovaDel Pharma, Inc. to produce NovaDel's
nitroglycerin lingual spray for the treatment of acute angina under an exclusive
five-year arrangement. The completed agreement was released to Registrant on
November 30, 2004.
Item 7.01 Regulation FD Disclosure
On November 23, 2004, Registrant issued a press release announcing the
NovaDel agreement. A copy of this press release is attached as Exhibit 99.1.
The press release is being furnished, and shall not be deemed to be
"filed", with the SEC. The information in Exhibit 99.1 shall not be incorporated
by reference into any filing of the Registrant with the SEC, whether made before
or after the date hereof, regardless of any general incorporation language in
such filings.
Item 9.01. Financial Exhibits, Pro Forma Financial Information and Exhibits.
10.33 Manufacturing and Supply Agreement
99.1 Press Release dated November 23, 2004.
SIGNATURES
Pursuant to the requirement of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
INYX, INC.
By: /s/ Jack Kachkar
----------------------
Jack Kachkar, Chairman
Dated: November 30, 2004